Maria (Myriam) Hunink, MD, PhD was honored for her career achievements at a symposium and celebratory event held at the Nieuwe Instituut, Rotterdam, the Netherlands last month.
Benefit-cost analysis is well-established and widely used to inform policy decisions. Its normative foundations are explored in “Ethics and Benefit-Cost Analysis,” a special issue of the Journal of Benefit-Cost Analysis. The issue was organized and edited by CHDS Deputy Director Lisa Robinson.
CHDS’s Ole Norheim served as one of the editors to the fourth edition of the Disease Control Priorities (DCP-4) Country-Led Priorities Setting for Health volume, released last month.
Conventional methods for valuing health and longevity have several well-known limitations. In a CHDS seminar, Maddalena Ferranna discussed social welfare function analysis, which addresses the drawbacks of these methods.
CHDS’ Nicolas Menzies recently participated in a panel discussion on Advances in Genomic Surveillance and Tuberculosis Diagnosis, hosted by Harvard T.H. Chan School of Public Health.
